Almoosa 2025 net profit soars to SAR 236.5M; Q4 at SAR 82M

11/03/2026 Argaam Exclusive

Content Summary:

Loading data...

Comments Analysis:

Positive: 0%
Neutral: 0%
Negative: 0%
Comments Summary:Loading data...
Please note that this news summary has been generated using artificial intelligence. It is recommended to review the original sources for complete details and to verify the accuracy of the information.

Almoosa Health Co. reported a net profit surge to SAR 236.5 million for 2025, from SAR 49.4 million in the year-earlier period.

 


Financials (M)

Item 2024 2025 Change‬
Revenues 1,202.34 1,416.29 17.8 %
Gross Income 371.72 448.60 20.7 %
Operating Income 168.66 203.03 20.4 %
Net Income 49.35 236.54 379.3 %
Average Shares 35.00 44.30 26.6 %
Earnings Per Share before unusual items (Riyals) 2.70 4.46 65.4 %
EPS (Riyal) 1.41 5.34 278.6 %

This was primarily driven by higher revenue from increased patient volumes and admissions, as well as a more favorable case mix with a higher proportion of complex and specialized procedures. The increase was also supported by the expansion of clinical services through the addition of new clinics across various specialties, which enhanced service capacity and contributed to higher patient activity.

 

Profitability was further supported by improved operational efficiency and stronger cost management across the group’s hospitals and medical centers. In addition, the group recorded lower finance costs following the settlement of certain financing facilities earlier in the year after the IPO, which positively impacted the bottom line.

 

The company’s operating profit for 2025 increased to SAR 225.7 million, following the classification of the loss on investment as a non-operating item.

 

Net profit for the period was also affected by non-cash items arising from the mark-to-market valuation of derivative instruments and treatment of fair value loss on investments.



Current Quarter Comparison (M)

Compared With The
Item Q4 2024 Q4 2025 Change‬
Revenues 332.11 387.96 16.8 %
Gross Income 119.95 120.29 0.3 %
Operating Income 69.69 49.84 (28.5 %)
Net Income 8.96 82.00 815.3 %
Average Shares 35.00 44.30 26.6 %
Earnings Per Share before unusual items (Riyal) 1.54 1.03 (33.0 %)
EPS (Riyal) 0.26 1.85 623.1 %

Q4 2025 net earnings surged to SAR 82 million, compared to SAR 9.01 million in Q4 2024.

 

On a sequential basis, net profit jumped 58.7% from SAR 51.64 million in Q3 2025.

 

Total shareholders’ equity rose to SAR 1.92 billion by Dec. 31, 2025, compared to SAR 626.3 million in the prior-year period.

 

Attached Documents

 

 

 

View More Financial Results

 

View other reports